Zobrazeno 1 - 10
of 191
pro vyhledávání: '"V A Larionova"'
Publikováno v:
Acta Biomedica Scientifica, Vol 8, Iss 4, Pp 117-125 (2023)
Background. People who previously had COVID-19 infection have an increased risk of developing cardiovascular diseases. Left ventricular diastolic dysfunction is an early marker of the development of cardiac pathology. Its early detection is important
Externí odkaz:
https://doaj.org/article/f2976b7231d5446ba7207c0809fdc05f
Autor:
V. B. Larionova, D. A. Bykov
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 62-71 (2022)
Externí odkaz:
https://doaj.org/article/5b5dc84623354781bafb1d5336741a83
Publikováno v:
Онкогематология, Vol 17, Iss 1, Pp 135-142 (2022)
Neutropenia is the most common hematologic toxicity of chemotherapy. Severe and prolonged neutropenia can cause treatment delay and dose reduction. Clinical studies indicate that reducing the relative dose intensity of regimens harms treatment outcom
Externí odkaz:
https://doaj.org/article/319756eaae184dc292ea240fa395fb8f
Autor:
F. Sh. Kamolova, L. Yu. Grivtsova, S. M. Samborskiy, V. B. Larionova, Yu. E. Ryabukhina, P. A. Zeynalova, A. M. Mudunov
Publikováno v:
Онкогематология, Vol 16, Iss 3, Pp 50-57 (2021)
Background. Extramedullary plasmacytoma (EP) of soft tissues, which in most cases affects the organs of the head and neck region, is a relatively rare malignant tumor. Until now, there are no consensus approaches to the diagnosis and treatment of EP.
Externí odkaz:
https://doaj.org/article/6536143ea55949d98e9ef665495a0a9a
Autor:
A. A. Polyakov, V. V. Lunin, F. M. Abbaysbeyli, O. L. Timofeeva, V. B. Larionova, P. A. Zeynalova, A. A. Fedenko
Publikováno v:
Онкогематология, Vol 16, Iss 2, Pp 70-80 (2021)
The objective of the study a detailed, systematic review of the world literature data, which includes all aspects of recommendations for vaccination against SARS-COV‑2 in cancer patients.Materials and methods. Information search was carried out in
Externí odkaz:
https://doaj.org/article/62a57377abd842d9aa2f29c21b5d2ba2
Publikováno v:
Онкогематология, Vol 16, Iss 1, Pp 64-72 (2021)
Bone metastasis is one of the most common manifestations of advanced malignant process. Many tumors, especially breast, prostate and lung cancer, multiple myeloma, are characterized by a high incidence of bone damage (up to 7080 %) and clinical compl
Externí odkaz:
https://doaj.org/article/f4413ed86c344f249b456938ad219f6f
Autor:
V. B. Larionova, A. V. Snegovoy
Publikováno v:
Онкогематология, Vol 15, Iss 4, Pp 65-81 (2020)
Background. In modern oncohematology achieved notable success due to the intensification and development of new chemotherapy regimens. However, the side effects of anticancer drugs, due to low selectivity of most of them, are a serious limitation to
Externí odkaz:
https://doaj.org/article/843d772ccab34931baed64c92eba1ebf
Publikováno v:
Онкогематология, Vol 15, Iss 4, Pp 91-102 (2020)
Background. Modern standards for the treatment of both solid tumors and tumors of the blood system provide a mandatory assessment of the objective status of the patient. One of the important criteria of which is nutritional status. Underestimating th
Externí odkaz:
https://doaj.org/article/8b13b89691da4f31a94d53d0f1e59152
Autor:
V. B. Larionova, A. V. Snegovoy
Publikováno v:
Онкогематология, Vol 15, Iss 3, Pp 107-127 (2020)
Finding opportunities to improve treatment outcomes of cancer patients remains a difficult and unresolved problem. Modern anticancer treatment due to the intensity and molecular biological orientation allows achieving higher efficiency and theoretica
Externí odkaz:
https://doaj.org/article/14fb069380e7490a819c6d453659e24d
Autor:
A. A. Semenova, A. V. Arakelyan, P. A. Zeynalova, G. S. Tumyan, V. B. Larionova, T. T. Valiev, F. M. Abbasbeyli, O. L. Timofeeva, A. S. Antipova, O. A. Lopuhova
Publikováno v:
Онкогематология, Vol 15, Iss 3, Pp 27-37 (2020)
Background. Bendamustine is one of the main drugs included in the arsenal of cytostatic agents that are used in oncohematology. In Russia, the drug was registered at the end of 2010 under the commercial name Ribomustin (company Astellas). At the end
Externí odkaz:
https://doaj.org/article/f7743929421443c792891e8c506a08ee